FRINK Linked Data Fragments server

Matches in SemOpenAlex for { <https://semopenalex.org/work/W4308139719> ?p ?o ?g. }

• W4308139719 endingPage "A58" @default.
• W4308139719 startingPage "A57" @default.
• W4308139719 abstract "Abstract Background Primary aldosteronism (PA) is associated with a high burden of cardiometabolic complications such as coronary heart disease, atrial fibrillation, left ventricular hypertrophy, stroke and chronic kidney disease. It is therefore essential to screen, confirm the diagnosis and then implement a targeted treatment, to lower the rate of these complications. According to the latest Endocrine Society guidelines for the management of PA, unilateral adrenalectomy is recommended when the secretion of aldosterone is mostly coming from one adrenal. If the secretion is bilateral or if the patient refuse surgery, medical treatment with mineralocorticoid receptor antagonist is indicated. Nevertheless, there are limited data comparing these two treatments on their impact on the number and dosage of anti-hypertensive drugs needed to control the disease. Objective The objective was to compare the impact of medical or surgical treatment on the antihypertensive defined daily dose (DDD) after 6 months of treatment in our cohort of PA patients followed at the CHUS. We've also evaluated the kalemia, blood pressure and renin after 6 and 12 months of treatment. Long term blood pressure control has also been evaluated. Methodology To answer this question, we conducted a single-center retrospective cohort study. Adults followed at CHUS between 2000 and 2021, with a confirmed diagnosis of PA and a follow-up of at least 6 months were included. Pregnancy was the only exclusion criteria. The primary outcome was the variation in the antihypertensiveDDD in patients medically treated compared to those surgically treated after 6 months. Results A total of 46 patients were included in our cohort, from which 28 were medically treated. Patients in the surgical group were younger, had a higher diastolic blood pressure and aldosterone/renin ratio. Among the 18 patients who underwent unilateral adrenalectomy, only 6 of them had a clearly lateralized secretion confirmed by adrenal veins sampling. At 6 months, the antihypertensive DDD variation was statistically significantly higher in the surgical group, with a decrease of 1.7 compared to a decrease of 0.6 in the medical group. Even after age, diastolic blood pressure and aldosterone/renin ratio adjustments, the difference between the 2 groups remains statistically significant, with a p value of 0. 033. Conclusion These results indicate that the surgical treatment of patient with primary aldosteronism leads to a greater DDD decrease at 6 months, even after adjusting for disease severity and despite the fact that the surgical group is not exclusively unilateral. However, the impact of disease control on long-term outcomes could not be assessed due to missing data. Presentation: No date and time listed" @default.
• W4308139719 created "2022-11-08" @default.
• W4308139719 creator A5011247499 @default.
• W4308139719 creator A5066593219 @default.
• W4308139719 date "2022-11-01" @default.
• W4308139719 modified "2023-09-30" @default.
• W4308139719 title "ODP038 Efficacy of Medical Treatment Compared to Unilateral Adrenalectomy in a Cohort of Patients with Primary Aldosteronism Treated at the Centre Hospitalier Universitaire de Sherbrooke – CHUS" @default.
• W4308139719 doi "https://doi.org/10.1210/jendso/bvac150.119" @default.
• W4308139719 hasPublicationYear "2022" @default.
• W4308139719 type Work @default.
• W4308139719 citedByCount "0" @default.
• W4308139719 crossrefType "journal-article" @default.
• W4308139719 hasAuthorship W4308139719A5011247499 @default.
• W4308139719 hasAuthorship W4308139719A5066593219 @default.
• W4308139719 hasBestOaLocation W43081397191 @default.
• W4308139719 hasConcept C126322002 @default.
• W4308139719 hasConcept C126894567 @default.
• W4308139719 hasConcept C141071460 @default.
• W4308139719 hasConcept C2776869705 @default.
• W4308139719 hasConcept C2778525890 @default.
• W4308139719 hasConcept C2780087391 @default.
• W4308139719 hasConcept C2780233176 @default.
• W4308139719 hasConcept C46699223 @default.
• W4308139719 hasConcept C71315377 @default.
• W4308139719 hasConcept C71924100 @default.
• W4308139719 hasConcept C72563966 @default.
• W4308139719 hasConcept C84393581 @default.
• W4308139719 hasConceptScore W4308139719C126322002 @default.
• W4308139719 hasConceptScore W4308139719C126894567 @default.
• W4308139719 hasConceptScore W4308139719C141071460 @default.
• W4308139719 hasConceptScore W4308139719C2776869705 @default.
• W4308139719 hasConceptScore W4308139719C2778525890 @default.
• W4308139719 hasConceptScore W4308139719C2780087391 @default.
• W4308139719 hasConceptScore W4308139719C2780233176 @default.
• W4308139719 hasConceptScore W4308139719C46699223 @default.
• W4308139719 hasConceptScore W4308139719C71315377 @default.
• W4308139719 hasConceptScore W4308139719C71924100 @default.
• W4308139719 hasConceptScore W4308139719C72563966 @default.
• W4308139719 hasConceptScore W4308139719C84393581 @default.
• W4308139719 hasIssue "Supplement_1" @default.
• W4308139719 hasLocation W43081397191 @default.
• W4308139719 hasLocation W43081397192 @default.
• W4308139719 hasOpenAccess W4308139719 @default.
• W4308139719 hasPrimaryLocation W43081397191 @default.
• W4308139719 hasRelatedWork W2041887457 @default.
• W4308139719 hasRelatedWork W2117303303 @default.
• W4308139719 hasRelatedWork W2258860024 @default.
• W4308139719 hasRelatedWork W2269511738 @default.
• W4308139719 hasRelatedWork W2604240645 @default.
• W4308139719 hasRelatedWork W2760934378 @default.
• W4308139719 hasRelatedWork W2780430485 @default.
• W4308139719 hasRelatedWork W3033766956 @default.
• W4308139719 hasRelatedWork W3036438771 @default.
• W4308139719 hasRelatedWork W2091748136 @default.
• W4308139719 hasVolume "6" @default.
• W4308139719 isParatext "false" @default.
• W4308139719 isRetracted "false" @default.
• W4308139719 workType "article" @default.